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1. Introduction   
Ventricular arrhythmia was once regarded uncommon in infants and children, since most 
cardiac arrests were thought to be hypoxia-induced bradycardia followed by asystole. 
Furthermore, ischemic heart disease, the basis for many of the ventricular arrhythmias in 
adults, is rare in pediatric patients. However, with the advent of pediatric critical care, 
improved techniques of extracorporeal life support, increasing awareness of genetic 
abnormalities, and a growing population of patients with congenital heart diseases, 
ventricular arrhythmia is being recognized more frequently in pediatric patients, and is 
becoming a larger management issue.  
Pediatric critical care is a special field that rapid diagnosis and intervention are often 
essential. These interventions may be life-saving or sometimes debilitating, depending on 
their appropriateness and timeliness. The spectrum of cardiac arrhythmias in the pediatric 
intensive care unit (PICU) ranges from those that are immediately life threatening to those 
with little or no hemodynamic consequences. However, patients in the PICU often have 
hemodynamic instability, poor cardiac reserve or structural cardiac defects so that they are 
especially vulnerable to arrhythmia-induced cardiac dysfunction. Therefore, early 
recognition and prompt management of life-threatening ventricular arrhythmias are 
essential aspects of the care that must be provided to these patients. Indeed, given with the 
heterogeneity of diseases and complexity of structural heart defects in the pediatric critical 
care setting, treatment must frequently be provided in the PICU even before the specific 
cardiac diagnosis is made. To meet this challenge, the management of life-threatening 
ventricular arrhythmias in children will be the most effective if these arrhythmias are 
anticipated by the pediatric intensivist.  
The aims of this chapter are to provide an update, from the standpoint of pediatric critical care, 
regarding comprehensive concepts of (1) non-cardiac clinical entities associated with 
ventricular arrhythmias, such as electrolyte imbalance, hypothermia, infection and drugs; (2) 
cardiac entities associated with ventricular arrhythmias, such as dilated cardiomyopathy, 
hypertrophic obstructive cardiomyopathy, and congenital heart diseases post cardiac surgery; 
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(3) genetic abnormalities associated with ventricular arrhythmias, including conditions such as 
long QT syndrome, arrhythmogenic right ventricular cardiomyopathy, and Brugada 
syndrome; and (4) management of ventricular arrhythmias in the PICU.  
2. Non-cardiac clinical entities associated with ventricular arrhythmias  
In a multidisplinary PICU, although it is appropriate to consider ventricular arrhythmias as 
a problem of cardiac origin, other noncardiac etiologies should not be overlooked. Table 1 
shows the systemic causes of ventricular arrhythmias. 
 
Electrolyte imbalance 
Hyperkalemia 
Hypokalemia 
Hypomagnesemia 
Hypocalcemia 
Hypothermia 
Cold stress 
Therapeutic hypothermia 
Extracorporeal life support 
Infectious 
Systemic viral infections causing myocarditis 
Systemic bacterial infections causing endocarditis 
Sepsis-induced cardiomyopathy 
Drugs 
Catecholamine 
Quinidine 
Procainamide 
Digitalis  
Psychotropic medications 
Traumatic Displacement of central venous catheters 
 
Table 1. Systemic clinical entities associated with ventricular arrhythmia 
2.1 Electrolyte imbalance  
Serum electrolyte imbalance is very common in patients in the PICU for many non-cardiac 
reasons. Potassium is the one with the greatest chances to cause ventricular arrhythmias 
(Schaefer et al., 2005). For, example, we have previously demonstrated a case of life-
threatening ventricular arrythmias and hyperkalemia induced by tumor lysis syndrome 
during the surgical biopsy (Lee et al., 2007). Hyperkalemia causes electrocardiographic 
changes before it reaches the serum potassium levels that cause arrhythmia. With modest 
hyperkalemia, the T wave will become narrow and peaked. Pediatric patients with faster 
resting heart rates tend to have narrower T waves, and peaked T waves may not be 
immediately evident. The QRS widens with higher levels of potassium. With extremely high 
serum potassium, ventricular tachycardia and fibrillation will ultimately occur. 
Hypokalemia causes prolonged QT-U interval and prominent U waves. Although less 
common than hyperkalemia, hypokalemia may also induce polymorphic ventricular 
tachycardia or ventricular fibrillation. Different from the devastating effect of potassium, 
imbalance of serum calcium and magnesium rarely cause significant arrhythmia.  
2.2 Hypothermia 
Hypothermia can slow the rate of sinus rhythm induce ventricular arrhythmia. Mild 
hypothermia results in the development of QT interval prolongation. Deep hypothermia 
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results in AV block and subsequently ventricular arrhythmia and fibrillation (Pilichou  
et al., 2006). With the emergence of hypothermia as a critical management in the ICU, 
such as to improve the outcome especially in the survivors of out-of-hospital cardiac 
arrest and neonatal asphyxia, ventricular arrhythmia can be a growing issue to be 
concerned. Indeed, recent case reports have demonstrated occurrences of ventricular 
tachycardia, fibrillation, and Torsade de pointes during the procedure of hypothermia 
(Schaefer et al., 2005; Matsuhashi et al., 2010), suggesting that monitoring temperature 
levels is very important as the risk of life-threatening may induced by deep hypothermia 
less than 32°C.   
2.3 Infection 
Systemic infection may cause sinus tachycardia due to an increase in metabolic  
demand. Endocarditis near the normal conduction system may cause AV block by direct 
damaging conduction system. Myocarditis, one of the most common pediatric acquired 
heart diseases, is often associated with ventricular tachyarrhythmia. Myocarditis may not 
always be the primary source of infection but may complicate systemic infection, such as 
viremia or viral encephalitis For example, enteroviral infection is one of the most common 
causes of fulminant myocarditis secondary to systemic infection in the setting of pediatric 
critical care (Figure 1.). Rheumatic heart disease, a complication of group A streptococcal 
infection, may cause transient or permanent AV block and sinus node dysfunction.  
Lyme disease, transmitted by the bite of a tick infected with Borrelia burgdorferi, is  
also known to cause AV block and other cardiac conduction abnormalities (Lo et al., 
2003). 
 
 
Fig. 1. EKG of ventricular tachycardia in a child with enteroviral encephalitis complicated 
with fulminant myocarditis. 
2.4 Drugs 
Drugs commonly administered in the PICU such as exogenous catecholamines, digoxin, and 
antiarrhythmic drugs may possess potential proarrhythmic effects. Although the arrhythmic 
effects of exogenous catecholamines are usually immediately recognized and treated, 
digoxin toxicity may be more difficult to be recognized due to its insidious effect. Renal 
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function impairment in critically ill patients and administration of medications affecting 
digoxin metabolism are common in the PICU. Digitalis toxicity can result in many forms of 
arrhythmia. Treatment of digitalis toxicity has been simplified with the availability of 
digoxin-immune Fab antibody therapy. Toxicity with other antiarrhythmic drugs has 
become less frequent, such as the use of quinidine and procainamide.  
3. Cardiac entities associated with ventricular arrhythmias  
In the PICU, ventricular arrhythmias are often associated cardiac diseases. We herein 
discuss common cardiac diseases including dilated cardiomyopathy, hypertrophic 
cardiomyopathy and congenital heart diseases.  
3.1 Dilated cardiomyopathy 
Dilated cardiomyopathy (DCM) is the most common severe cardiomyopathy, accounting for 
more than 50% of pediatric cardiomyopathy (Jefferies et al., 2010). Etiology of DCM includes 
immunologic, familial, metabolic, infectious, toxic and neuromuscular causes. These 
patients are prone to ventricular arrhythmia. Treatment is targeted at symptoms, ventricular 
dysfunction and underlying rhythm disturbance. Prophylactic use of implantable cardiac 
defibrillator in the pediatric population is not well established as in adults with ischemic 
cardiomyopathies. In patients with muscular dystrophy, DCM is also common and may be a 
potential cause of mortality in these patients due to ventricular arrhythmia. Figure 3 shows 
non-sustained ventricular tachycardia and a premature ventricular contraction in a patient 
with Duchenne muscular dystrophy complicated with DCM. 
 
 
 
Fig. 2. A patient of Duchenne muscular dystrophy with dilated cardiomyopathy presented 
with chest pain. The Holter EKG record revealed non-sustained ventricular tachycardia and 
a premature ventricular beat. 
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3.2 Hypertrophic cardiomyopathy 
Patients with hypertrophic cardiomyopathy comprise a subgroup with myocardial 
disease that is prone to ventricular arrhythmias. Left ventricular outflow tract obstruction 
may cause coronary artery insufficiency and myocardial ischemia, thus resulting in 
ventricular arrhythmias. Microscopically, hypertrophic cardiomyopathy shows 
disorganization of the cardiac muscle cells, a substrate for arrhythmia. Indeed, this 
microscopic finding seems to put these patients at risk regardless of the degree of outflow 
tract obstruction. Non-sustained ventricular tachycardia is common in children with 
hypertrophic cardiomyopathy. Clinical risk factors of sudden death include family history 
of cardiac arrest, increased QRS duration, myocardial bridging of the left coronary artery, 
increased QT dispersion, ventricular wall thickness, exercise-induced hypotension, and 
syncope. 
3.3 Congenital heart disease post cardiac surgery 
Ventricular arrhythmia has a reported incidence of 1–5% among pediatric patients and 
adults who have had palliative surgery for congenital heart disease (CHD) (Gatzoulis et al., 
2000; Deanfield et al., 1980; Vetter et al., 1982; Kavey et al., 1982). With the advent of surgical 
technique and postoperative care, ventricular arrhythmia and sudden death have been 
reported as causes of early, intermediate and late morbidity and mortality (Garson et al., 
1979). Congenital heart diseases are associated with various types of arrhythmia, depending 
on specific lesions, as shown in Table 3. 
 
 
Congenital heart disease arrhythmia 
Tetralogy of Fallot   Atrial tachycardia  
Double outlet right ventricl 
Ventricular tachycardia 
Sinus node dysfunction 
Transposition of the great arteries 
Ventricular arrhythmias                                      
Atrioventricular block  
Ebstein's anomaly Supraventricular tachycardia  
Ventricular septal defect repair 
Heart block                                        
Ventricular arrhythmias  
Atrial septal defect       Atrial tachycardia 
Atrial septal defect repair   Sinus node dysfunction 
Table 2. Congenital heart disease and associated arrhythmias 
Occurrence of ventricular arrhythmia is particularly well known after the repair of tetralogy 
of Fallot (TOF). To relieve the obstruction of right ventricular outflow tract in TOF, it is 
always necessary for the surgeon to make a right ventricular outflow tract incision, to 
augment the outflow tract region, and repair the ventricular septal defect with a patch. 
Thus, the scar after surgical procedures may create a complex substrate for the development 
of arrhythmias. 
Postoperative ventricular arrhythmias have been previously found in 5-10% of patients on 
the 12-lead ECG and in 40-60% on 24-hour Holter EKG in patients undergoing surgery 
(Garson et al., 1990). The advent of surgical techniques and repair at a younger age have led 
to a significant reduction in the incidence of arrhythmias. In fact, transatrial repair has been 
www.intechopen.com
 Cardiac Arrhythmias – New Considerations 
 
294 
confirmed to have a beneficial effect on the incidence of ventricular arrhythmias. For 
example, a study comparing the incidence of arrhythmias in two groups of patients who 
underwent transventricular or transatrial repair showing that in the former group, 39.4% 
had significant ventricular arrhythmias, while in the latter group only 2.8% had significant 
arrhythmias (Dietl et al., 1994). 
In addition to ventricular arrhythmias, sudden cardiac death is also an important issue and 
has been reported in 1.5-5% of patients after repair of TOF. In fact, ventricular arrhythmias 
have been regarded as a controversial etiological factor of sudden cardiac death (Garson et 
al., 1980; Katz et al., 1982; Quattlebaum et al., 1975). For example, it has been reported that 
previous ventricular arrhythmias were found in 100%of patients who died suddenly, 
compared to 12%of those who did not (Garson et al., 1985). On the other hand, another 
study followed patients with TOF post surgery for 12 years and found no correlation 
between the degree of ventricular arrhythmias and sudden death (Cullen et al., 1994). 
Therefore, some studies were aimed to elucidate the relationship between ECG indices and 
the risk of ventricular tachycardia and sudden death. A QRS duration >180 ms was found to 
be a very sensitive predictor for the development of VT and sudden death (Gatzoulis et al., 
1995), so is the use of a transannular patch in combination with severe pulmonary valve 
insufficiency (Gatzoulis et al. , 2000). Furthermore, QT dispersion has also been suggested as 
risk factor of sustained ventricular tachycardia (Gatzoulis et al., 1997). Factors associated 
with the development of ventricular tachycardia in patients with TOF are summarized in 
Table 2.  
 
Older age at repair 
Earlier surgical era 
Residual ventricular septal defect  
Prior systemic-to-pulmonary artery shunt 
Trans-annular right ventricular outflow tract patch 
Right ventricular pressure overload 
Right ventricular volume overload 
Ventricular arrhythmias 
Atrial arrhythmias 
Complete heart block 
QRS duration >180 mini-seconds 
 
Table 3. Proposed risk factors for ventricular tachycardia and sudden death after repair of 
tetralogy of Fallot 
Patients with other cardiac lesions may also be at risk for ventricular arrhythmias. Patients 
with aortic stenosis seem to be the highest risk group (Wolfe et al., 1993), with an increased 
mortality risk in patients with greater outflow tract gradients. Thus, all patients with 
repaired and unrepaired congenital heart disease should be considered at increased risk for 
ventricular arrhythmias and associated morbidity, including sudden death. 
Notably, some atypical forms of supraventricular tachycardia can mimic ventricular 
tachycardia, such as supraventricular tachycardia with right bundle branch block after 
repair of TOF or double outlet of right ventricle (Figure 3). However, a wide QRS complex 
tachycardia in a patient who is hemodynamically unstable should be treated as ventricular 
tachycardia until proven otherwise. 
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Fig. 3. Upper panel: The EKG of a patient with double outlet of right ventricle post palliative 
repair. Even with wide QRS, the inverted p wave following every QRS in aVL suggests 
supraventricular tachycardia instead of ventricular tachycardia. Lower panel: Another 
episode of ventricular tachycardia recorded in the lead II EKG strip in the same patient. 
4. Genetic abnormalities associated with ventricular arrhythmias  
Various forms of genetic abnormality-associated with ventricular arrhythmia may place a 
child at risk for sudden cardiac death. Although some diseases are clinically obvious, 
cardiovascular collapse may be the first symptom in others. Studies of sudden cardiac death 
and ventricular arrhythmia have therefore focused on identification of patients with the 
genetic abnormalities, including long QT syndrome, arrhythmogenic right ventricular 
dysplasia and Brugada syndrome. 
4.1 Long QT syndrome  
The congenital long QT syndrome (LQTS) is a rare but important clinical disorder, with the 
prevalence of 1 to 2500 live births. It includes two hereditary variants under the unifying 
name of "Long QT syndrome" (Schwartz et al., 1975). One is associated with deafness, Jervell 
and Lange-Nielsen syndrome (Jervell et al., 1957; Schwartz et al., 2006), and one is not, 
Romano-Ward syndrome (Romano et al., 1963; Ward et al., 1964). Long-QT syndrome has 
been subdivided into types based on the gene in which causative mutations occur. The most 
prevalent forms are LQT1 and LQT2 (mutations in potassium channels), and LQT3 
(mutation in a sodium channel). The clinical manifestations of the disease may be life-
threatening including syncope, cardiac arrest and sudden death. Electrocardiographic and 
genetic features of LQTS are discussed below. 
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4.1.1 Electrocardiographic features 
4.1.1.1 QT interval duration 
The Bazett's correction for heart rate remains a very useful clinical tool. Conventionally, QTc 
values in excess of 440 ms are considered prolonged; however, values up to 460 ms may still 
be normal among females (Merri et al., 1989). The longer QT values among women and 
becoming evident only after puberty suggest a role for hormonal changes (Stramba et al., 
1995). Even though syncope occurs also in patients with modest QT prolongation or even 
with a normal QT interval., however, it is believed that the longer the QT, the greater is the 
risk for malignant arrhythmias. In fact, when QTc exceeds 500–550 ms, there is a definite 
increase in risk (Priori et al., 2003; Moss et al., 1991) 
4.1.1.2 T wave morphology 
In LQTS both the duration of repolarization and its morphology are altered. The T wave is 
often biphasic or notched because of regional differences in the time course of ventricular 
repolarization, especially prominent in the precordial leads. (Figure 4) 
 
 
Fig. 4. The 12-lead EKG of a 13 year-old girl with long QT syndrome with the clinical 
presentation of recurrent syncopes. The QTc is 645 ms, with typical biphasic T waves in  
V2 and V3. 
4.1.1.3 T wave alternans 
Beat-to-beat alternation of the T wave is a marker of electrical instability suggesting the 
diagnosis of LQTS. It may be present at rest but most commonly appears during emotional 
or physical stresses and may sometimes precede torsades de pointes.   
4.1.1.4 Sinus pauses 
Sudden pauses in sinus rhythm longer than 1.2 seconds that are not related to sinus 
arrhythmia may be present in LQTS patients and may contribute to the initiation of 
ventricular arrhythmias. Their occurrence in LQT3 patients represents an important 
warning signal that warrants further life-saving management. 
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4.1.2 Genetic etiologies of LQTS 
Since 1995, following the first identification of the first three LQTS genes associated with the 
most frequently encountered LQTS variants LQT1, LQT2, and LQT3, there has been 
growing identifications of genes associated with LQTS (Wang et al., 1995; Curran et al., 1995; 
Wang et al., 1996) including the genes for LQT4 through LQT10 (Table 3)  
 
LQTS subtypes Gene Prevalence (%)  
LQT1  KCNQ1 50 
LQT1  KCNQ1 35 
LQT2 KCNH2 10 
LQT3 SCN5A <5 
LQT4 ANK2 <5 
LQT5  KCNE1 <5 
LQT6 KCNE2 <5 
LQT7  KCNJ2 <5 
LQT8  CACNA1c <5 
LQT9 CAV3 <5 
LQT10 SCN4B <5 
Table 4. Long QT syndrome (LQTS) subtypes, disease-associated genes and prevalenc 
4.1.3 Association between sudden infant death syndrome and LQTS 
Sudden infant death syndrome (SIDS) is the leading cause of sudden death during the first 
year of life. The causes of SIDS remain a mystery, even with a lot of theories focused on 
dysfunctional control of respiratory or cardiac function (Schwartz et al., 1988). However, 
there are some evidence showing the association between SIDS and LQTS. For example, a 
large cohort study measuring the QT interval during the first week of life in more than 
30,000 infants and following them for occurrence of SIDS demonstrated that infants who 
died of SIDS had a longer QTc than the survivors and the victims from other causes 
(Schwartz et al., 1998). In addition, in a study of Norway (Arnestad et al., 2007), based on 
201 SIDS victims and 187 controls, mutations in LQTS genes were identified. These data 
justify the rationale of neonatal ECG screening and the guidelines proposed by the Task 
Force of the European Society of Cardiology (Schwartz et al., 2002) Therefore, future aim is 
the prevention of those sudden deaths due to unrecognized LQTS which may result in SIDS.  
4.2 Arrhythmogenic right ventricular dysplasia 
Arrhythmogenic right ventricular dysplasia (ARVD) is a predominantly genetically 
determined and heritable form of cardiomyopathy that may lead to right ventricular failure, 
ventricular arrhythmias, and sudden cardiac death. It is uniquely characterized by the 
replacement of myocytes by adipose and fibrous tissue in histology. The estimated prevalence 
of ARVD ranges from 1 in 2,000 to 1 in 5,000, with a predominance in men than women, with 
an approximate ratio of 3:1 (Corradoet al., 2006). Twelve genes have been identified to be 
associated with ARVD (Table 4). These genes are responsible for encoding several components 
of the cardiac desmosome. Dysfunctional desmosomes cause defective cell adhesion proteins, 
such as plakoglobin (JUP), desmoplakin (DSP), plakophilin-2 (PKP-2), and desmoglein-2 
(DSG-2) consequently cause loss of electrical coupling between cardiomyocytes, leading to 
death of cardiomyocyte, fibrous replacement of myocardium and finally arrhythmias 
(Rampazzo et al., 2002 ; McKoy et al., 2000; Gerull et al., 2004; Pilichou et al., 2006). Diagnosis is 
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based on the finding a combination of characteristic abnormalities in family history, 
electrocardiography, cardiac imaging especially MRI and biopsy.  
 
ARVD type Chromosome/locus Gene codes Mode of transmission 
ARVD type 1 14q23 – q24 TGFβ-3 Autosomal dominant 
ARVD type 2 1q42 – q43 RyR2 Autosomal dominant 
ARVD type 3 14q12 – q22  Autosomal dominant 
ARVD type 4 2q32  Autosomal dominant 
ARVD type 5 3q23 
Transmembrane protein 
43 
Autosomal dominant 
ARVD type 6 10p12 – p14  Autosomal dominant 
ARVD type 7 10q22  Autosomal dominant 
ARVD type 8 6p24 Desmoplakin(DSP) Autosomal dominant 
ARVD type 9 12p11 Plakophilin-2(PKP2) Autosomal dominant 
ARVD type 10 18q12 Desmoglein-2(DSG2) Autosomal dominant 
ARVD type 11 18q12.1 Desmocollin-2(DSC2) Autosomal dominant 
ARVD type 12 17q21 Plakoglobin(JUP) Autosomal dominant 
Naxos Disease 17q21 Plakoglobin(JUP) Autosomal recessive 
Table 5. Genes mutations associated with arrhythmogenic right ventricular dysplasia 
Therapeutic options are limited due to the progressive course of ARVD. Competitive 
athletics should be avoided. It is generally believed that patients who meet the Task Force 
criteria for ARVD are at high risk for sudden cardiac death and should undergo ICD 
placement (Marcus et al., 2010). The role of electrophysiologic study and catheter ablation in 
ARVD is not well established, and but it is frequently used as a palliative measure in the 
setting of refractory ventricular tachycardia. Even though sotalol may be effective in 
patients with ARVD and ventricular tachycardia, heart transplantation is the choice for 
patients with refractory ventricular arrhythmias and progressive heart failure. 
4.3 Brugada syndrome 
Brugada syndrome is a genetic disease characterized by the occurrence of cardiac 
arrhythmias and sudden cardiac death in young individuals without evidence of structural 
heart disease. In fact, Brugada syndrome is associated with structural and functional 
abnormalities in the sodium channel. Because of the absence of structural heart 
abnormalities, Brugada syndrome is classified as a cardiac “channelopathy”. 
Genetic studies have determined that more than one gene is capable of causing this syndrome. 
Initially, mutations in only one gene, SCN5A, encoding the cardiac sodium channel, have been 
identified. Recently, flourishing gene mutations have been identified, such as mutations in the 
CACNA1c and CACNB2b genes, coding the calcium channels, and mutations in the KCNE3 
gene, coding a subunit of the potassium channel (Antzelevitch et al., 2007; Delpón et al., 2008). 
There is some evidence showing that the electrical disorders associated with Brugada 
syndrome are mainly located in the right ventricle, particularly in the outflow tract of right 
ventricle. These patients typically present an ECG pattern characterized by ST segment 
elevation in the right precordial leads and a RBBB (Brugada et al., 1992). 
Brugada syndrome is thought to be responsible for 4% to 12% of all sudden cardiac death 
and for up to 20% of sudden cardiac death in subjects without structural heart disease 
(Brugada et al., 2002). Sudden cardiac death associated with Brugada syndrome is caused by 
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polymorphic ventricular tachycardia or ventricular fibrillation (Antzelevitch et al., 2006). 
Unfortunately, because the ECG is often dynamic and concealed, it is difficult to estimate 
the real prevalence of this disease (Nademanee et al., 1997). However, it is believed that the 
prevalence is less frequent in western countries and higher in Southeast Asia. In fact, 
Brugada syndrome is considered to be the major cause of natural death in young 
individuals in Thailand and the Philippines (Miyasaka et al., 2001; Donohue et al., 2008). 
5. Management of ventricular arrhythmias in the PICU 
The major issue for a pediatric intensivist regarding management of ventricular arrhythmias in 
the PICU is to cope with postoperative arrhythmias in patients with congenital heart diseases 
(CHD). In these patients, ventricular arrhythmias may occur in the early postoperative stage, 
caused by surgical procedure, or in the late stage, caused by a residual structural defect or scar 
tissue. In addition to early and late postoperative management, catheter ablation and 
implantable cardioverter-defibrillators (ICD) will also be discussed in this section. 
5.1 Early postoperative ventricular arrhythmias 
Early postoperative arrhythmias are defined as occurrence within the first 10 days after 
surgery. Patients with CHD who have hemodynamically unstable early postoperative 
ventricular tachycardia or ventricular fibrillation require immediate treatment, as suggested 
by the AHA guidelines for cardiopulmonary resuscitation. After stabilizing the airway and 
breathing, cardiopulmonary resuscitation should be started immediately (Kleinman et al., 
2010). If the ventricular tachycardia persists after cardiopulmonary resuscitation, 
synchronized electrical cardioversion (0.5–1.0 J/kg) should be administered. If a second 
shock (2.0 J/kg) is unsuccessful, amiodarone or procainamide should be considered before 
administering a third shock. If the ventricular arrhythmias are successfully converted to 
sinus rhythm, potential causes for the ventricular arrhythmias must be identified. In patients 
without identifiable causes, close observation and administration of intravenous 
antiarrhythmic medications are necessary.  
Amiodarone is the antiarrhythmic treatment for pulseless ventricular tachycardia 
recommended by the AHA Committee on Resuscitation guidelines. Amiodarone dosing 
should adhere to the following regimen for pediatric patients: an intravenous bolus 
administered at 5–10 mg/kg and then maintenance infusion at 5–15 mg/kg/day. The safety 
and efficacy of amiodarone has been documented in studies performed in children with 
CHD (Drago F et al., 1998). For patients with stable ventricular tachycardia, the dosage and 
desired levels of antiarrhythmic medications are shown in Table 6. 
 
Drug Dosage Desired  level 
Propranolol 0.05 - 0.1 mg/kg/dose q6h 20 - 150 ng/ml 
Procainamide 
Loading: 5 - 15 mg/kg in 30 min 
Infusion: 20 – 80 μg/kg/min 4 – 8 μg/ml 
Lidocaine 
Loading: 1 - 2 mg/kg in 30 min 
Infusion: 10 – 50 μg/kg/min 1-5 μg/ml 
Mexiletine 3 - 5 mg/kg/dose q8h 0.5 - 2.0 μg/ml 
Amiodarone 
Loading: 5 - 10 mg/kg in 30 min 
Infusion: 5 - 15 mg/kg/day 
1.5 - 2.5 μg/ml 
Table 6. Pharmacologic management of ventricular tachycardia in pediatric patients. 
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5.2 Late postoperative ventricular arrhythmias 
All patients with CHD who have undergone surgery are at risk of late postoperative 
ventricular arrhythmias. Therefore, they require follow-up for routine electrocardiography 
to evaluate the patient’s conduction system for potential bundle branch block. Evaluation of 
sinus node function, abnormalities of ST and T wave, and premature ventricular contraction 
are important, since these abnormalities can trigger the occurrence of ventricular 
tachycardia or sudden death in these patients. In addition, Holter EKG can detect 
asymptomatic ventricular arrhythmias in patients with CHD, for example in up to 9% of 
postoperative TOF (Chandar et al., 1990). Furthermore, the electrophysiologic study with 
programmed ventricular stimulation may have a role in the risk stratification because some 
investigators found that the induction of polymorphic VT could predict VT and sudden 
cardiac death (Khairy et al., 2004). The most common types of CHD associated with 
postoperative ventricular arrhythmia are listed in Table 7. 
 
Tetralogy of Fallot  
Trasposition of great arteries 
Aortic stenosis 
Ventricular septal defect  
Atrail septal defect, secundum type 
Atrial septal defect, primum type 
Aortic coarctation 
Pulmonary stenosis 
 
Table 7. Types of congenital heart defects commonly associated with postoperative 
ventricular arrhythmia.  
5.3 Catheter ablation 
There is some recent evidence addressing the role of catheter ablation in the treatment of 
ventricular tachycardia in CHD patients. For example, in a study of 10 patients with TOF 
who received noncontact mapping due to hemodynamically unstable ventricular 
tachycardia (Kriebelet al., 2007), ablation was achieved in eight patients and for all of them 
ventricular tachycardia was not inducible at the end of the procedure. Another study of 
electroanatomical contact mapping and catheter ablation in patients with ventricular 
tachycardia after repair of CHD demonstrated that isthmuses between patches and tricuspid 
annulus, right ventricular outflow tract, or pulmonary annulus were responsible for the 
reentrant tachycardias (Zeppenfeld et al., 2007). Ablation of these isthmuses abolished all 
ventricular tachycardias. Accordingly, there is a potential role for ventricular tachycardia 
ablation in patients after repair of CHD. 
5.4 Implantable cardioverter-defibrillators 
An implantable cardioverter-defibrillator (ICD) is recommended in CHD patients with a 
positive ventricular stimulation in the electrophysiology study. However, it is sometimes 
highly technical to implant a cardioverter-defibrillator transvenously in these patients due to 
their structural anomaly and small size of these patients. In addition, implanting a transvenous 
ICD system in patients with intracardiac shunting is not recommended, because the risk of 
thromboembolic events. The implantation of a transvenous ICD in patients younger than 8 
years of age can be a high-risk procedure because of complications such as venous occlusion, 
infection or wound dehiscence because of limited prepectoral tissue.  
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Surgical implantation is required when an ICD cannot be implanted transvenously. As such, 
the generator or device is implanted in the abdomen with the leads sewn into the 
epicardium. This surgical method is associated with some complications including 
postpericardiotomy syndrome, constrictive pericarditis, lead-induced trauma and lead 
failure (Stefanelli et al., 2002; Ketteringet al., 2004). Recent reports have described less 
invasive ways to implant an epicardial ICD in patients who are either too small or have 
mixing lesions (Cannon et al., 2006; Snyder et al., 2007). An additional problem is that 
patients may receive inappropriate shocks for sinus tachycardia due to improper 
programming. Accordingly, before programming an ICD in a patient with repaired CHD, 
patients should undergo exercise testing to determine their peak heart rate. Notably, some 
patients require adjuvant therapy with either nadolol or amiodarone, even with an ICD, to 
limit their peak heart rate and decrease chances of inappropriate shocks. 
6. Conclusions 
Ventricular tachycardias in the setting of PICU are a diverse group of rhythm disorders 
different from those seen in the adults with ischemic heart disease. They are not only 
different in ventricular substrates and etiologies, but also in the electrophysiologic 
mechanisms. Furthermore, ventricular arrhythmia after surgery for CHD requires a 
comprehensive evaluation including the clinical state of the patient, the cardiac anatomy, 
previous surgical history, and the electrophysiologic patterns of the arrhythmia. Most 
importantly, ventricular arrhythmia is an important cause of sudden death in the infants 
and children, so pediatric intensivists should be familiar with risk factors and emergent 
management of these life-threatening scenarios to ensure a better outcome.  
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